SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001472375-24-000045
Filing Date
2024-06-24
Accepted
2024-06-24 12:02:27
Documents
59
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT FOR THE FISCAL YEAR ENDED MARCH 31, 2024 ixform10k.htm   iXBRL 10-K 604371
2 CERTIFICATION exhibit31-1.htm EX-31.1 12208
3 CERTIFICATION exhibit31-2.htm EX-31.2 12032
4 CERTIFICATION exhibit32-1.htm EX-32.1 4353
5 CERTIFICATION exhibit32-2.htm EX-32.2 4296
6 regenerexlogo.gif GRAPHIC 5716
  Complete submission text file 0001472375-24-000045.txt   3311820

Data Files

Seq Description Document Type Size
7 SCHEMA DOCUMENT rgpx-20240331.xsd EX-101.SCH 30844
8 CALCULATION LINKBASE DOCUMENT rgpx-20240331_cal.xml EX-101.CAL 38702
9 DEFINITION LINKBASE DOCUMENT rgpx-20240331_def.xml EX-101.DEF 128023
10 LABELS LINKBASE DOCUMENT rgpx-20240331_lab.xml EX-101.LAB 218957
11 PRESENTATION LINKBASE DOCUMENT rgpx-20240331_pre.xml EX-101.PRE 188986
62 EXTRACTED XBRL INSTANCE DOCUMENT ixform10k_htm.xml XML 347540
Mailing Address 5348 VEGAS DRIVE, SUITE 177 LAS VEGAS NV 89108
Business Address 5348 VEGAS DRIVE, SUITE 177 LAS VEGAS NV 89108 305-927-5191
REGENEREX PHARMA, INC. (Filer) CIK: 0001357878 (see all company filings)

IRS No.: 980479983 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 000-53230 | Film No.: 241062988
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)